Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of older age on outcomes of rTMS treatment for treatment-resistant depression.
Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Einstein EH, Oughli HA, Leuchter AF. Leuchter MK, et al. Among authors: citrenbaum c. Int Psychogeriatr. 2024 Mar 25:1-6. doi: 10.1017/S1041610224000462. Online ahead of print. Int Psychogeriatr. 2024. PMID: 38525670
A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression.
Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Leuchter AF. Leuchter MK, et al. Among authors: citrenbaum c. Psychiatry Res. 2023 Dec;330:115608. doi: 10.1016/j.psychres.2023.115608. Epub 2023 Nov 14. Psychiatry Res. 2023. PMID: 37984281
Pretreatment pupillary reactivity is associated with differential early response to 10 Hz and intermittent theta-burst repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD).
Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke SA, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Leuchter MK, Strouse TB, Corse A, Vyas P, Leuchter AF. Citrenbaum C, et al. Brain Stimul. 2023 Nov-Dec;16(6):1566-1571. doi: 10.1016/j.brs.2023.10.006. Epub 2023 Oct 18. Brain Stimul. 2023. PMID: 37863389 Free article.
Right lateral orbitofrontal cortex inhibitory transcranial magnetic stimulation for treatment of refractory mood and depression.
Tadayonnejad R, Citrenbaum C, Ngo TDP, Corlier J, Wilke SA, Slan A, Distler MG, Hoftman G, Adelekun AE, Leuchter MK, Koek RJ, Ginder ND, Krantz D, Artin H, Strouse T, Bari AA, Leuchter AF. Tadayonnejad R, et al. Among authors: citrenbaum c. Brain Stimul. 2023 Sep-Oct;16(5):1374-1376. doi: 10.1016/j.brs.2023.09.011. Epub 2023 Sep 15. Brain Stimul. 2023. PMID: 37716637 Free article. No abstract available.
Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).
Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke S, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Strouse T, Corse A, Vyas P, Leuchter AF. Citrenbaum C, et al. J Affect Disord. 2023 Oct 15;339:412-417. doi: 10.1016/j.jad.2023.07.008. Epub 2023 Jul 10. J Affect Disord. 2023. PMID: 37437737 Free article.
Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder.
Tadayonnejad R, Wilson AC, Chu SA, Corlier J, Citrenbaum C, Ngo TDP, Hovhannisyan E, Ginder ND, Levitt JG, Wilke SA, Krantz D, Bari AA, Leuchter AF. Tadayonnejad R, et al. Among authors: citrenbaum c. Psychiatry Res. 2022 Nov;317:114856. doi: 10.1016/j.psychres.2022.114856. Epub 2022 Sep 20. Psychiatry Res. 2022. PMID: 36155277